company background image
300463 logo

Maccura BiotechnologyLtd SZSE:300463 Stock Report

Last Price

CN¥12.52

Market Cap

CN¥7.9b

7D

-8.2%

1Y

-32.4%

Updated

27 Mar, 2024

Data

Company Financials +

Maccura Biotechnology Co.Ltd

SZSE:300463 Stock Report

Market Cap: CN¥7.9b

300463 Stock Overview

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally.

300463 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Maccura Biotechnology Co.Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Maccura BiotechnologyLtd
Historical stock prices
Current Share PriceCN¥12.52
52 Week HighCN¥19.05
52 Week LowCN¥9.90
Beta0.39
1 Month Change-1.34%
3 Month Change-16.48%
1 Year Change-32.36%
3 Year Change-69.19%
5 Year Change-41.33%
Change since IPO-6.71%

Recent News & Updates

Recent updates

Shareholder Returns

300463CN Life SciencesCN Market
7D-8.2%-7.2%-2.2%
1Y-32.4%-42.9%-14.8%

Return vs Industry: 300463 exceeded the CN Life Sciences industry which returned -42.9% over the past year.

Return vs Market: 300463 underperformed the CN Market which returned -14.8% over the past year.

Price Volatility

Is 300463's price volatile compared to industry and market?
300463 volatility
300463 Average Weekly Movement6.4%
Life Sciences Industry Average Movement9.3%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.4%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 300463 has not had significant price volatility in the past 3 months.

Volatility Over Time: 300463's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19942,758Wu Mingjianhttps://www.maccura.com

Maccura Biotechnology Co Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers.

Maccura Biotechnology Co.Ltd Fundamentals Summary

How do Maccura BiotechnologyLtd's earnings and revenue compare to its market cap?
300463 fundamental statistics
Market capCN¥7.86b
Earnings (TTM)CN¥375.99m
Revenue (TTM)CN¥3.01b

20.4x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300463 income statement (TTM)
RevenueCN¥3.01b
Cost of RevenueCN¥1.38b
Gross ProfitCN¥1.62b
Other ExpensesCN¥1.25b
EarningsCN¥375.99m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)0.61
Gross Margin54.03%
Net Profit Margin12.51%
Debt/Equity Ratio12.1%

How did 300463 perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

57%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.